These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12592373)

  • 1. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan.
    Fletcher GC; Patel S; Tyson K; Adam PJ; Schenker M; Loader JA; Daviet L; Legrain P; Parekh R; Harris AL; Terrett JA
    Br J Cancer; 2003 Feb; 88(4):579-85. PubMed ID: 12592373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines.
    Thompson DA; Weigel RJ
    Biochem Biophys Res Commun; 1998 Oct; 251(1):111-6. PubMed ID: 9790916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
    Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
    J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.
    Sgambato A; Migaldi M; Montanari M; Camerini A; Brancaccio A; Rossi G; Cangiano R; Losasso C; Capelli G; Trentini GP; Cittadini A
    Am J Pathol; 2003 Mar; 162(3):849-60. PubMed ID: 12598319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and expression analysis of dystroglycan during Xenopus laevis embryogenesis.
    Lunardi A; Dente L
    Gene Expr Patterns; 2002 Nov; 2(1-2):45-50. PubMed ID: 12617836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content.
    Graham JD; Balleine RL; Milliken JS; Bilous AM; Clarke CL
    Eur J Cancer; 1997 Sep; 33(10):1654-60. PubMed ID: 9389930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-inducible Gene-2 (MIG2) and migfilin expression is reduced in samples of human breast cancer.
    Gkretsi V; Papanikolaou V; Zacharia LC; Athanassiou E; Wu C; Tsezou A
    Anticancer Res; 2013 May; 33(5):1977-81. PubMed ID: 23645746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of BRCA2 gene in sporadic breast tumours.
    Bièche I; Noguès C; Lidereau R
    Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and expression analysis of dystroglycan during Xenopus laevis embryogenesis.
    Lunardi A; Dente L
    Mech Dev; 2002 Dec; 119 Suppl 1():S49-54. PubMed ID: 14516660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
    Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
    J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
    Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
    J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.
    Hansen LV; Gårdsvoll H; Nielsen BS; Lund LR; Danø K; Jensen ON; Ploug M
    Biochem J; 2004 Jun; 380(Pt 3):845-57. PubMed ID: 15012588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.
    Al-Alwan M; Olabi S; Ghebeh H; Barhoush E; Tulbah A; Al-Tweigeri T; Ajarim D; Adra C
    PLoS One; 2011; 6(11):e27339. PubMed ID: 22076152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystroglycan is present in rat thyroid and rat thyroid cells and responds to thyrotropin.
    Collins BJ; Gorelick G; Schneider AB
    Endocrinology; 2001 Jul; 142(7):3152-62. PubMed ID: 11416038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
    Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
    Ding L; Niu C; Zheng Y; Xiong Z; Liu Y; Lin J; Sun H; Huang K; Yang W; Li X; Ye Q
    J Cell Mol Med; 2011 Jan; 15(1):72-85. PubMed ID: 19840196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
    Bu H; Schweiger MR; Manke T; Wunderlich A; Timmermann B; Kerick M; Pasqualini L; Shehu E; Fuchsberger C; Cato AC; Klocker H
    FEBS J; 2013 Mar; 280(5):1249-66. PubMed ID: 23294566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts.
    Esseghir S; Reis-Filho JS; Kennedy A; James M; O'Hare MJ; Jeffery R; Poulsom R; Isacke CM
    J Pathol; 2006 Dec; 210(4):420-30. PubMed ID: 17054309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.